NCT04259164View on ClinicalTrials.gov

Anti-inflammatory Effects Glycopyrronium

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

December 29, 2022

Study Completion Date

December 29, 2022

Conditions
AsthmaAllergic Asthma
Interventions
DRUG

QVM149

Anti-inflammatory effect of Glycopyrronium added to Mometasone / Indacaterol

DRUG

QMF149

Mometasone / Indacaterol

Trial Locations (1)

9713GZ

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT04259164 - Anti-inflammatory Effects Glycopyrronium | Biotech Hunter | Biotech Hunter